Breast Cancer Trial, Recruiting (NCT06729684)

Breast Cancer Trial, Recruiting NCT06729684 Sponsor: Samsung Medical Center Condition: Breast Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06729684 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Breast Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have had surgery for Stage 1 or Stage 2 breast cancer
You have had a mastectomy (removal of one breast) on one side only
You are between 18 and 64 years old
You own a smartphone that runs Android or iOS (such as a Samsung or iPhone)
You are willing to take part voluntarily and are able to sign a written consent form after being fully informed about the study

Who may not be able to join:

You have had a mastectomy but are not currently receiving any chemotherapy, radiation therapy, or hormone therapy
You have a serious health condition (such as a nerve or muscle disorder, a cognitive or mental health condition, a visual impairment, or another significant underlying illness) that would make it difficult to use a smartphone app or take part in an exercise program

Additional reasons you may need to leave the trial if you have already joined:

You have breast reconstruction surgery during the study period
You develop serious complications, or your cancer spreads or comes back during the study, requiring a change in your treatment
You develop a serious illness that is unrelated to the study
You are unable to follow the instructions given by the study doctor
You choose to withdraw from the study at any point, or become unable to continue for any reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06729684

Sponsor: Samsung Medical Center

Phase: Not Applicable

Status: Recruiting

Condition: Breast Cancer

More information: https://clinicaltrials.gov/study/NCT06729684

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have had surgery for Stage 1 or Stage 2 breast cancer
You have had a mastectomy (removal of one breast) on one side only
You are between 18 and 64 years old
You own a smartphone that runs Android or iOS (such as a Samsung or iPhone)
You are willing to take part voluntarily and are able to sign a written consent form after being fully informed about the study

Who may not be able to join:

You have had a mastectomy but are not currently receiving any chemotherapy, radiation therapy, or hormone therapy
You have a serious health condition (such as a nerve or muscle disorder, a cognitive or mental health condition, a visual impairment, or another significant underlying illness) that would make it difficult to use a smartphone app or take part in an exercise program

Additional reasons you may need to leave the trial if you have already joined:

You have breast reconstruction surgery during the study period
You develop serious complications, or your cancer spreads or comes back during the study, requiring a change in your treatment
You develop a serious illness that is unrelated to the study
You are unable to follow the instructions given by the study doctor
You choose to withdraw from the study at any point, or become unable to continue for any reason

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Samsung Medical Center

Registry

ClinicalTrials.gov

Start date

13 November 2024

Est. completion

31 May 2025

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

PROMIS29

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov